Dr Shania Liu scoops new International Pharmacy Federation (FIP) award

FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is emerging internationally. The inaugural award went to Dr Shania Liu. Dr Liu completed her PhD on reducing persistent postoperative opioid use at the University of Sydney, Australia. She has published more than 20 articles in leading peer-reviewed journals. She has also led national pain management training as chair of the Society of Hospital Pharmacists of Australia Pain Management Leadership Committee. Her research has shaped national guidelines on pain management and is cited in the Australian and New Zealand College of Anaesthetists Position Statement on Acute Pain Management. Dr Liu’s advocacy against modified-release opioids for postoperative pain has also influenced practices internationally, including those of the UK Royal College of Anaesthetists. She is a member of FIP’s Hospital Pharmacy Section and chair of its Communication and Digital Engagement Committee. Her global impact is further highlighted by international collaborations with universities in Canada, the UK and the USA, as well as a recent postdoctoral appointment at the University of Alberta.

Dr Liu’s recent publication, A pilot multicentre randomised clinical trial to determine the effect of a pharmacist-partnered opioid tapering intervention before total hip or knee arthroplasty, reports the findings of the OpioidHALT study.

From left to right: Luis Lourenço, FIP professional secretary; Paul Sinclair, FIP president; Shania Liu

Picture courtesy of FIP